Ezetimibe significantly lowers low-density lipoprotein cholesterol in subjects with primary hypercholesterolaemia

被引:0
|
作者
Lipka, LJ
Knopp, RH
Gitter, H
Truitt, T
机构
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
[2] NW Lipid Res Clin, Seattle, WA USA
[3] Jersey Res Fdn Inc, Linwood, NJ USA
[4] Hlth Adv Inst, Melbourne, FL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:252 / 252
页数:1
相关论文
共 50 条
  • [1] Ezetimibe significantly reduces low-density lipoprotein cholesterol in homozygous familial hypercholesterolemia
    Gagne, C
    Gaudet, D
    Bruckert, E
    Ponsonnet, D
    Lipka, L
    LeBeaut, A
    Suresh, R
    Abreu, P
    Veltri, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 227A - 227A
  • [2] Treatment of Ezetimibe lowers total and low-density lipoprotein cholesterol in hypercholesterolemic dogs with hyperadorenocorticism
    Oda, Hitomi
    Haga, Aiko
    Koyama, Kaoru
    Gokita, Kureha
    Akiyama, Ran
    Komiya, Takumi
    Hasegawa, Shinogu
    Sako, Toshinori
    Mori, Akihiro
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2024, 86 (04): : 363 - 367
  • [3] Fenofibrate lowers small low-density lipoprotein with no change in total low-density lipoprotein cholesterol
    Superko, HR
    Madan, S
    Tonnemacher, D
    Chronos, N
    Garrett, B
    Sheehan, D
    Raul, E
    Frohwein, S
    McGrath, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 316A - 316A
  • [4] Getting there: Statin plus ezetimibe for low-density lipoprotein cholesterol
    Hurley, DL
    Isley, WL
    MAYO CLINIC PROCEEDINGS, 2005, 80 (05) : 585 - 586
  • [5] CLINICAL EFFICACY OF EZETIMIBE AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOALS
    Pascual, J. M.
    Rodilla, E.
    Sanchez, C.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2006, 18 (02): : 57 - 60
  • [6] Total and low-density lipoprotein cholesterol responses to ezetimibe in clinical practice
    Capps, N.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (07) : 867 - 869
  • [7] Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition
    Marcusa, Daniel P.
    Giugliano, Robert P.
    Park, Jeong-Gun
    de Lemos, James A.
    Cannon, Christopher P.
    Sabatine, Marc S.
    JAMA CARDIOLOGY, 2021, 6 (05) : 582 - 586
  • [8] The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia
    Florentin, Matilda
    Liberopoulos, Evangelos N.
    Moutzouri, Elisavet
    Rizos, Christos V.
    Tselepis, Alexandros D.
    Elisaf, Moses S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (03) : 685 - 692
  • [9] Oral semaglutide significantly reduces low-density lipoprotein cholesterol level
    Shuichi Okada
    Kazuya Okada
    Junichi Okada
    Koji Kikkawa
    Eijiro Yamada
    Tsugumichi Saito
    Tetsuro Andou
    Kihachi Ohshima
    International Journal of Diabetes in Developing Countries, 2024, 44 : 366 - 368
  • [10] Oral semaglutide significantly reduces low-density lipoprotein cholesterol level
    Okada, Shuichi
    Okada, Kazuya
    Okada, Junichi
    Kikkawa, Koji
    Yamada, Eijiro
    Saito, Tsugumichi
    Andou, Tetsuro
    Ohshima, Kihachi
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (02) : 366 - 368